ArticleCancer immunology, immunotherapy : CII2013

A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer.

Daniela Fenoglio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.